Millipore Corporation Announces Effective Date of Make-Whole Fundamental Change and Increase in Conversion Rate Due to Make-Whole Fundamental Change Relating to Its 3.75% Convertible Senior Notes Due 2026

BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that Merck KGaA (“Merck”) has completed its acquisition of Millipore (the “Acquisition”) as of July 14, 2010. As part of the transaction, all issued and outstanding shares of Millipore common stock were exchanged for $107 per share in cash.